Literature DB >> 9688435

Antihypertensive medication in clinical encounters.

K I Kjellgren1, S Svensson, J Ahlner, R Säljö.   

Abstract

In managing hypertension, patient participation and understanding of the nature and significance of treatment are decisive. We analysed the communication between patient and physician with respect to antihypertensive medication at a follow-up appointment, and assessed patients' knowledge of their medication. The empirical data consist of audio-recordings from 51 hypertensive patients' follow-up appointment with their physicians. Thirty-three of these patients were interviewed in depth immediately after the appointment. The study was performed in primary health care centres and at a specialist clinic for hypertension. When discussing medications, patients mainly talked about experiences of being on medication, whereas physicians generally focused on the pharmacological effect and dosage of the drug. Physicians routinely asked about compliance with drug regimen, but seldom in any depth. Little effort was invested into discussing the effect and goal of therapy. The main finding was that patients had a very fragmentary understanding of the functional nature of their antihypertensive medication. This is unsatisfactory both from the point of view of treatment efficacy and also when considering the legal requirements of involving the patient in the decision making. The follow-up appointments studied gave few possibilities for the patient to learn about their antihypertensive medication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688435     DOI: 10.1016/s0167-5273(98)00038-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Awareness of the side effects of possessed medications in a community setting.

Authors:  Panagiotis N Papanikolaou; John P A Ioannidis
Journal:  Eur J Clin Pharmacol       Date:  2003-03-07       Impact factor: 2.953

2.  The effect of patient-provider communication on medication adherence in hypertensive black patients: does race concordance matter?

Authors:  Antoinette Schoenthaler; John P Allegrante; William Chaplin; Gbenga Ogedegbe
Journal:  Ann Behav Med       Date:  2012-06

Review 3.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

4.  How do providers assess antihypertensive medication adherence in medical encounters?

Authors:  Barbara G Bokhour; Dan R Berlowitz; Judith A Long; Nancy R Kressin
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

5.  Addressing the Social Needs of Hypertensive Patients: The Role of Patient-Provider Communication as a Predictor of Medication Adherence.

Authors:  Antoinette Schoenthaler; George J Knafl; Kevin Fiscella; Gbenga Ogedegbe
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-09

6.  Patients' decisions about whether or not to take antihypertensive drugs: qualitative study.

Authors:  John Benson; Nicky Britten
Journal:  BMJ       Date:  2002-10-19

Review 7.  Hypertension and current issues in compliance and patient outcomes.

Authors:  T M Zyczynski; K S Coyne
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 8.  A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance.

Authors:  Fiona A Stevenson; Kate Cox; Nicky Britten; Yenal Dundar
Journal:  Health Expect       Date:  2004-09       Impact factor: 3.377

9.  Drug attitude and adherence: a qualitative insight of patients with hypertension.

Authors:  F Saleem; Ma Hassali; Aa Shafie; M Atif
Journal:  J Young Pharm       Date:  2012-04

10.  Developing an interactive mobile phone self-report system for self-management of hypertension. Part 1: patient and professional perspectives.

Authors:  Ulrika Bengtsson; Dick Kasperowski; Lena Ring; Karin Kjellgren
Journal:  Blood Press       Date:  2014-02-24       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.